GCC markets pioglitazone tablets

Published: 2008-08-20 06:59:00
Updated: 2008-08-20 06:59:00
Green Cross Corp. has launched Glulis (pioglitazone) tablets with an aim to strengthen its diabetic sector in addition to glimepiride and metformin.

Pioglitazone is a prescription drug of the class thiazolidinedione with hypoglycemic action. It is used for the treatment of diabetes mellitus ty...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.